secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2024-10-22T23:59:59+00:00
Accession:  0001683168-24-007283
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma expands Medline distribution to Canada and OTC retail in US and Canada
-----------------------------------------------------------------------------

- Amendment No. 1 to Distribution Agreement with Medline dated Oct 17, 2024 adds Canada and OTC wound care sales to retailers.
- Original 5-year US distribution deal signed Aug 19, 2024; now covers both countries and OTC channel.
- Updated investor presentation (Oct 22, 2024) highlights 20% YoY European revenue growth in Q1 FY2025 and gross margin improvement to 39%.
- New FDA 510(k) clearance received Sep 2024 for OTC face/eyelid/eyelash indications and smaller product size.
- Distribution expanded in Ukraine, South Korea, and EU through new partners in 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316824007283/0001683168-24-007283-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316824007283/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-007283

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer